Latest Biotech News

The FDA has approved a new injectable form of Eisai and Biogen's Alzheimer's drug Leqembi, enabling weekly maintenance dosing that patients can receive at home. This marks a significant regulatory...

Eli Lilly has strategically terminated two of the three ongoing phase 2 trials of its oral GLP-1 candidate naperiglipron citing 'strategic business reasons,' while continuing a pivotal trial...

Several breakthroughs in oncology were reported including the identification of CBFA2T3 as a prognostic biomarker in lung adenocarcinoma, the unveiling of SC134-deruxtecan, an antibody-drug...

In cutting-edge AI developments, UCLA engineers introduced a wearable noninvasive brain-computer interface co-pilot system that deciphers user intent, advancing neurotechnology applications....

Recent studies have advanced understanding in metabolic diseases including insulin resistance surrogates as predictors of diabetic kidney disease and cholesterol ratios associated with insulin...

Progress in oncology includes new AI-enabled diagnostic tools such as OncoMet deep learning for esophageal cancer progression and fecal miR-92a biomarker screening for colorectal cancer. CAR...

August saw notable funding rounds in health technology, reflecting increased investment in innovative biotech ventures. Royalty Pharma acquired an up-to $950 million royalty interest in Amgen’s...

New research is uncovering mechanisms underlying brain-related diseases and functions. Studies revealed unique brain signaling differentiating Parkinson’s disease from essential tremor, links...

Emerging studies report potential of umbilical cord mesenchymal stem cells combined with melatonin in treating premature ovarian failure, and bone marrow stem cell-derived exosomes promoting...

A study in African cities highlights expanding urban gullies caused by inadequate drainage and rapid urbanization, displacing thousands and threatening infrastructure. Researchers warn this hazard...

Teva Pharmaceuticals received FDA approval for the first generic glucagon-like peptide-1 (GLP-1) agonist aimed at weight management, targeting adults struggling with excess weight and adolescents...

Royalty Pharma secured a royalty interest in Amgen’s Imdelltra (tarlatamab-dlle), an immunotherapy for extensive-stage small cell lung cancer (ES-SCLC), in a deal worth up to $950 million....

Researchers have developed SeeMe, an AI-powered tool that decodes subtle facial movements in comatose patients, revealing signs of covert consciousness undetectable by clinicians. By capturing...

Scientists wielding artificial intelligence have mined venom proteomes from snakes, spiders, and scorpions to uncover potent new antimicrobial peptides addressing the global crisis of antibiotic...

A cutting-edge technique employing DNA-wrapped nanoparticles as delivery vehicles has significantly enhanced the efficiency of CRISPR-Cas9 genome editing by threefold. This breakthrough in genetic...

A multicenter retrospective cohort study has yielded new evidence supporting the use of optimized pharmacological treatment protocols in managing acute type A aortic dissection, a critical...

Researchers have developed Pythia, a deep learning framework that predicts optimal repair templates for CRISPR-Cas9 genome editing, addressing challenges of precision, especially in non-dividing...

Mount Sinai researchers unveiled an advanced Graph Neural Network-based AI that analyzes large-scale electronic health records to precisely identify atrial fibrillation patients who require...

Australian researchers have leveraged citizen participation via RabbitScan to enhance the monitoring of rabbit hemorrhagic disease virus (RHDV) strains used as biocontrol agents against invasive...

Research demonstrates that multisystem exercise interventions significantly improve balance and functional mobility in individuals with diabetic peripheral neuropathy, a prevalent complication of...